AKT1 and breast cancer: Nevertheless, Zhang et al. (2022) recently introduced a randomized clinical trial to evaluate the effects of Yanghe decoction combined with neo-adjuvant chemotherapy in BC patients and the mechanism of action mediated via the PI3K/Akt/NF-κB pathway-mediated immune-inflammation microenvironment [213].